Rilonacept in Subjects With Cardiac Sarcoidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rilonacept in Subjects With Cardiac Sarcoidosis — Stella

Home/Cardiac Sarcoidosis/

View on ClinicalTrials.gov

Recruiting

Back to Cardiac Sarcoidosis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Johns Hopkins University, Baltimore, Maryland

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Phase

Safety & dosing

Sponsor

Mayo Clinic

Collaborators

Johns Hopkins University

Enrollment target

~60 participants

Started

March 2025

Primary completion

November 2026

Age range

18 Years – 80 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.